Κωδικός Προϊόντος	Όνομα Προϊόντος	Μέγεθος	Τιμή
MBS6130484-5x01mL	CD96 (T-cell Surface Protein Tactile, Cell Surface Antigen CD96, T Cell-activated Increased Late Expression Protein) (AP)	5x0.1mL	4180 EURO
MBS7071634-INQUIRE	Recombinant Saccharomyces cerevisiae Increased recombination centers protein 23 (IRC23), partial	INQUIRE	0 EURO
OS802e	Osteosarcoma and chondrosarcoma tissue array, including TNM and clinical stage, 80 cases/80 cores, replacing OS802c	row: 8; column: 10; cores: 80; cases: 80	389.4 EURO
RC239489	PMS1 (myc-DDK-tagged) - Human PMS1 postmeiotic segregation increased 1 (S. cerevisiae) (PMS1), transcript variant 4	10 µg	0 EURO
RC239490	PMS1 (myc-DDK-tagged) - Human PMS1 postmeiotic segregation increased 1 (S. cerevisiae) (PMS1), transcript variant 5	10 µg	0 EURO
RC226158	PMS1 (Myc-DDK-tagged)-Human PMS1 postmeiotic segregation increased 1 (S. cerevisiae) (PMS1), transcript variant 3	10 µg	0 EURO
RC226240	PMS1 (Myc-DDK-tagged)-Human PMS1 postmeiotic segregation increased 1 (S. cerevisiae) (PMS1), transcript variant 2	10 µg	0 EURO
RC226240L4	Lenti ORF clone of Human PMS1 postmeiotic segregation increased 1 (S. cerevisiae) (PMS1), transcript variant 2, mGFP tagged	10 µg	0 EURO
RC210880	PMS2 (Myc-DDK-tagged)-Human PMS2 postmeiotic segregation increased 2 (S. cerevisiae) (PMS2), transcript variant 1	10 µg	0 EURO
RC210880L2	Lenti ORF clone of Human PMS2 postmeiotic segregation increased 2 (S. cerevisiae) (PMS2), transcript variant 1, mGFP tagged	10 µg	0 EURO
RC210880L4	Lenti ORF clone of Human PMS2 postmeiotic segregation increased 2 (S. cerevisiae) (PMS2), transcript variant 1, mGFP tagged	10 µg	0 EURO
RC210950L3	Lenti ORF clone of Human postmeiotic segregation increased 2-like 3 (PMS2L3), transcript variant 1, Myc-DDK-tagged	10 µg	0 EURO
RC219898L1	Lenti ORF clone of Human fucosyltransferase 2 (secretor status included) (FUT2), transcript variant 1, Myc-DDK-tagged	10 µg	0 EURO
RC219898L3	Lenti ORF clone of Human fucosyltransferase 2 (secretor status included) (FUT2), transcript variant 1, Myc-DDK-tagged	10 µg	0 EURO
RC215830L3	Lenti ORF clone of Human fucosyltransferase 2 (secretor status included) (FUT2), transcript variant 2, Myc-DDK-tagged	10 µg	0 EURO
RC217412	PMS1 (Myc-DDK-tagged)-Human PMS1 postmeiotic segregation increased 1 (S. cerevisiae) (PMS1), transcript variant 1	10 µg	0 EURO
RC217412L2	Lenti ORF clone of Human PMS1 postmeiotic segregation increased 1 (S. cerevisiae) (PMS1), transcript variant 1, mGFP tagged	10 µg	0 EURO
RC217412L4	Lenti ORF clone of Human PMS1 postmeiotic segregation increased 1 (S. cerevisiae) (PMS1), transcript variant 1, mGFP tagged	10 µg	0 EURO
SC314899	(untagged)-Human cDNA FLJ20153 fis, clone COL08656, highly similar to AJ001381 Human incomplete cDNA for a mutated allele	10 µg	0 EURO
NCT808	Brain tumor tissue array with matched cancer adjacent or adjacent normal tissue, including pathology grade, 35 cases/80 cores	row: 8; column: 10; cores: 80; cases: 35	336.6 EURO
SC217146	3`UTR clone of fucosyltransferase 2 (secretor status included) (FUT2) transcript variant 2 for miRNA target validation	10 µg	0 EURO
SC217148	3`UTR clone of fucosyltransferase 2 (secretor status included) (FUT2) transcript variant 1 for miRNA target validation	10 µg	0 EURO
S-LUC2401M	Non-small cell lung cancer tissue array with survival data, including pathology grade, TNM and clinical stage, 120 cases/120 cores	row: 10; column: 12; cores: 120; cases: 120	1196.8 EURO
S-SCLC1361M	Lung small cell carcinoma and normal tissue microarray with survival data, including TNM and clinical stage, 68 cases/68 cores.	row: 7; column: 10; cores: 68; cases: 68	789.8 EURO
RR204053L3V	Lenti ORF particles, Pms1 (Myc-DDK-tagged ORF) - Rat PMS1 postmeiotic segregation increased 1 (S. cerevisiae) (Pms1), 200ul, >10^7 TU/mL	200 µl	0 EURO
SC210511	3`UTR clone of endogenous retroviral sequence 3 (includes zinc finger protein H-plk/HPF9) (ERV3) for miRNA target validation	10 µg	0 EURO
RR206498L3V	Lenti ORF particles, Pms2 (Myc-DDK-tagged ORF) - Rat PMS2 postmeiotic segregation increased 2 (S. cerevisiae) (Pms2), 200ul, >10^7 TU/mL	200 µl	0 EURO
UBD1921	Middle-advanced stage bladder cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores	row: 12; column: 16; cores: 192; cases: 96	297 EURO
UBD243a	Bladder cancer tissue array with cancer adjacent tissue, including TNM and clinical stage, 12 cases/24 cores, replacing BL243	row: 4; column: 6; cores: 24; cases: 12	85.8 EURO
UBD806c	Bladder cancer and bladder tissue array, including pathology grade, TNM and clinical stage, 66 cases/80 cores, replacing BL806b	row: 8; column: 10; cores: 80; cases: 66	336.6 EURO